Essential role for oncogenic Ras in tumour maintenance (original) (raw)

References

1. Bishop, J. M. Molecular themes in oncogenesis. Cell 64, 235–248 (1991).
   Article CAS Google Scholar
2. Gossen, M.et al. Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766–1769 (1995).
   Article ADS CAS Google Scholar
3. Fasano, O., Taparowsky, E., Fiddes, J., Wigler, M. & Goldfarb, M. Sequence and structure of the coding region of the human H-ras-1 gene from T24 bladder carcinoma cells. J. Mol. Appl. Genet. 2, 173–180 (1983).
   CAS PubMed Google Scholar
4. Kistner, A.et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl Acad. Sci. USA 93, 10933–10938 ( 1996).
   Article ADS CAS Google Scholar
5. Chin, L.et al. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev. 11, 2822– 2834 (1997).
   Article CAS Google Scholar
6. Thomson, T. M.et al. Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies. J. Invest. Dermatol. 90, 459 –466 (1988).
   Article CAS Google Scholar
7. Gause, P. R.et al. Chromosomal and genetic alterations of 7,12-dimethylbenz[a]anthracene-induced melanoma from TP-ras transgenic mice. Mol. Carcin. 20, 78–87 (1997).
   Article CAS Google Scholar
8. Shirasawa, S., Furuse, M., Yokoyama, N. & Sasazuki, T. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260, 85–88 ( 1993).
   Article ADS CAS Google Scholar
9. Doherty, P. C., Tripp, R. A. & Sixbey, J. W. Evasion of host immune responses by tumours and viruses. Ciba Found. Symp. 187, 245– 256 (1994).
   CAS PubMed Google Scholar
10. Bird, I. N., Spragg, J. H., Ager, A. & Matthews, N. Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunology 80 , 553–560 (1993).
    CAS PubMed PubMed Central Google Scholar
11. Traweek, S. T., Kandalaft, P. L., Mehta, P. & Battifora, H. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am. J. Clin. Pathol. 96, 25– 31 (1991).
    Article CAS Google Scholar
12. Rak, J.et al. Oncogenes as inducers of tumor angiogenesis. Cancer Metastasis Rev. 14, 263–277 ( 1995).
    Article CAS Google Scholar
13. Arbiser, J. L.et al . Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc. Natl Acad. Sci. USA 94, 861–866 (1997).
    Article ADS CAS Google Scholar
14. Okada, F.et al. Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proc. Natl Acad. Sci. USA 95, 3609– 3614 (1998).
    Article ADS CAS Google Scholar
15. Shweiki, D., Itin, A., Soffer, D. & Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843–845 (1992).
    Article ADS CAS Google Scholar
16. Mazure, N. M., Chen, E. Y., Yeh, P., Laderoute, K. R. & Giaccia, A. J. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res. 56, 3436–3440 (1996).
    CAS PubMed Google Scholar
17. Goldberg, M. A. & Schneider, T. J. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 269, 4355–4359 (1994).
    CAS PubMed Google Scholar
18. Mukhopadhyay, D.et al . Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375, 577–581 (1995).
    Article ADS CAS Google Scholar
19. Rak, J.et al. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res. 55 , 4575–4580 (1995).
    CAS PubMed Google Scholar
20. Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B. & Marme, D. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. Biol. Chem. 270, 25915–25919 (1995).
    Article CAS Google Scholar
21. Larcher, F.et al. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Res. 56, 5391–5396 ( 1996).
    CAS PubMed Google Scholar
22. Ganss, R., Montoliu, L., Monaghan, A. P. & Schutz, G. Acell-specific enhancer far upstream of the mouse tyrosinase gene confers high level and copy number-related expression in transgenic mice. EMBO J. 13, 3083–3093 ( 1994).
    Article CAS Google Scholar
23. Valenzuela, D. M.et al. Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscule, at the neuromuscular junction, and after injury. Neuron 15, 573– 584 (1995).
    Article CAS Google Scholar
24. Schreiber-Agus, N.et al. Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature 393, 483–487 (1998).
    Article ADS CAS Google Scholar
25. Gavrieli, Y., Sherman, Y. & Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493–501 ( 1992).
    Article CAS Google Scholar
26. Cheng, L., Fu, J., Tsukamoto, A. & Hawley, R. G. Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cells. Nature Biotech. 14, 606– 609 (1996).
    Article CAS Google Scholar

Download references